Peer-reviewed veterinary case report
Application of Ginsenoside Rd in Periodontitis With Inhibitory Effects on Pathogenicity, Inflammation, and Bone Resorption.
- Journal:
- Frontiers in cellular and infection microbiology
- Year:
- 2022
- Authors:
- Zhou, Shuhui et al.
- Affiliation:
- School and Hospital of Stomatology · China
Abstract
Periodontitis is a worldwide oral disease induced by the interaction of subgingival bacteria and host response and is characterized by local inflammation, bone resorption, and tooth loss. Ginsenoside Rd (Rd) is a biologically active component derived from Panax ginseng and has been demonstrated to exert antibacterial and anti-inflammatory activities. This study aims to investigate the inhibitory efficiency of Rd towards(), periodontal inflammatory response, and osteoclastogenesisand to further validate the results in a mouse periodontitis model, thus, evaluate the potential effects of Rd on the control and prevention of periodontitis. According to the results, Rd exerted excellent antibacterial activities against planktonic, along with attenuatingvirulence and inhibiting its biofilms. Meanwhile, the inflammatory cytokine production and osteoclastogenesis were remarkably inhibited by Rd bothand. Furthermore, Rd efficiently ameliorated the subgingivalabundance and suppressed the alveolar bone resorptionas well. In conclusion, Rd has the potential to be developed as a promising medication in the control and prevention of periodontitis.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/35480231/